News

Welcome to the news and media section of our website, where we feature corporate news releases and media coverage of interest.

 

vial of Immunocidin

ISU College of Veterinary Medicine to Conduct a Study with Immunocidin® in the Treatment of Canine Hemangiosarcoma

NovaVive's anticancer immunotherapeutic for dogs will be evaluated in a clinical study at Iowa State University (ISU) College of Veterinary Medicine in the treatment of splenic hemangiosarcoma (in combination with chemo).

World Health Organization poster

NovaVive Supports World Antibiotic Awareness Week

It's World Antibiotic Awareness Week and NovaVive is doing its part to help address the concern about antibiotic resistance by offering antibiotic alternatives for animals to the veterinary community and livestock/pet owners.

mother cow with calf

Amplimune® Receives Canadian OMRI Listing for Use in Organic Cattle Production

The Company's regulator-approved immunotherapy for calf scours, Amplimune®, has received an Organic Materials Review Institute (OMRI) Listing in Canada. This means that Amplimune may be used in organic cattle production.

dairy cows in barn eating hay

Mycobacterium Cell Wall Fraction (MCWF) Demonstrates Beneficial Efficacy in Dairy Cattle

NovaVive made two presentations at the World Buiatrics Congress in Sapporo, Japan today. Both presentations highlighted efficacy of MCWF in mature dairy cattle. More research is required, but these results are very promising.

head shot of Mark Hill

NovaVive Inc. Signs AABEX Animal Health to Provide U.S. Marketing Services

NovaVive Inc. has signed a marketing services agreement with AABEX Animal Health for the U.S.A. AABEX is a new animal health sales and marketing company founded by Mark Hill, a seasoned industry professional from Merial Ltd.

Dr. Jeannette Kelly with dog and sign that reads last chemo treatment

Immunocidin® Demonstrates an Acceptable Safety Profile Following Intravenous Administration in Dogs and Cats with Various Malignancies

Dr. Jeannette Kelly, veterinary oncologist with Veterinary Cancer Care, presented data from a study of multiple IV administrations of Immunocidin® in dogs and cats with various malignancies at the ACVIM Forum last week.

Sign up to stay up-to-date with NovaVive news.